# PREGABALIN
> **ANDA206452** · Abbreviated New Drug Application (Generic) · Sponsor: CADILA PHARMS LTD · Approved 2023-07-12
## Drug
- **FDA Application Number:** ANDA206452
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PREGABALIN
- **Generic name:** PREGABALIN
- **Active ingredients:** PREGABALIN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** CADILA PHARMS LTD
- **Manufacturer:** Cadila Pharmaceuticals Limited
- **First approval:** 2023-07-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206452)
---
*MORVS · CC0 1.0*